Related Experiment Video
Updated: May 5, 2026

08:50
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
11.6K
Sex-based differences in candidacy for transcatheter tricuspid valve intervention
Allison O Dumitriu Carcoana1, Christopher B Scoma2, Sebastian N Maletz1
1Morsani College of Medicine, University of South Florida Health, Tampa, Florida, USA.
Summary
Most patients with severe tricuspid regurgitation (TR) are ineligible for transcatheter tricuspid valve interventions (TTVI). Sex does not predict TTVI eligibility in this patient group.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Women exhibit higher prevalence and advanced stages of tricuspid regurgitation (TR) compared to men.
- Transcatheter tricuspid valve interventions (TTVI) offer a promising alternative to high-mortality tricuspid valve (TV) surgery.
- Exploration of sex-based differences in significant TR patients eligible for TTVI is crucial.
Purpose of the Study:
- To investigate sex-based disparities in eligibility for transcatheter tricuspid valve interventions (TTVI) among patients with significant tricuspid regurgitation (TR).
- To identify clinical and echocardiographic factors influencing TTVI eligibility across different sexes.
Main Methods:
- Retrospective analysis of 12,677 adult transthoracic echocardiograms (March 2021-2022).
- Inclusion of patients with more than moderate TR, defining eligibility for TTVI, TV surgery, or medical therapy based on 2021 ESC guidelines.
- Comparison of sex-based characteristics and TTVI eligibility using statistical tests and Cox regression for survival analysis.
Main Results:
- Of 569 patients with significant TR, 52% were female.
- Women presented with more isolated TR and TR due to pulmonary hypertension; men showed more left ventricular dysfunction and heart failure signs.
- A significant majority (over 75%) in both sexes were ineligible for TTVI or TV surgery due to advanced disease; 10.8% of women and 9.2% of men were TTVI-eligible (p=0.511).
Conclusions:
- The majority of patients with significant TR at tertiary centers are not candidates for TTVI.
- Sex is not a determining factor for TTVI eligibility in patients with significant TR.
- Further research is needed to optimize treatment strategies for the large proportion of TR patients ineligible for current interventions.

